NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC5563074/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC5563074/. The analysis below is for the second page.

Title[redir]:
GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation - PMC
Description:
1,25-dihydroxyvitamin D3 (1,25D), the biologically active form of vitamin D, is widely considered a promising therapy for acute myeloid leukemia (AML) based on its ability to drive differentiation of leukemic cells. However, clinical trials have ...

Matching Content Categories {📚}

Science
Education
Careers

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Ncbi.nlm.nih.gov might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

gsk, cells, aml, inhibition, differentiation, doi, vdr, combination, pubmed, google, scholar, activity, cell, fig, leukemia, treated, pmc, treatment, phosphorylation, signaling, article, jnk, growth, lithium, analysis, hours, cancer, kinase, regimen, leads, human, free, transcriptional, assay, dmediated, clinical, receptor, performed, study, inhibitor, enhances, myeloid, effects, low, studies, nmoll, ability, addition, activation, nbt,

Topics {✒️}

relative quantitative rt-pcr pmc beta search mh100×4-tk-luc plasmids trans retinoic acid real-time pcr phospho-ser208 vdr antibody gsk3β-deficient aml cells 25d-mediated anticancer activity fda-approved gsk3 inhibitor retinoic acid receptors constitutively active kinase gsk3-mediated inhibitory phosphorylation 25d-mediated differentiation reinforcing western blot analysis acute promyelocytic leukemia enhance differentiation-based therapy vdre-luciferase [kindly provided 25d-mediated growth inhibition acute myeloid leukemia 25d-mediated aml differentiation vitro kinase assays multi-tasking kinase advanced solid tumors superoxide-generating system established gsk3 inhibitors chemical gsk3 inhibitors fda-approved agent p-c-jun increasing transcriptional activity license information pmcid updated human knowledge casein kinase ii specific gsk3 inhibitors high-dose oral calcitriol publisher site pdf cell-cycle status myeloid leukemia cells rapidly dividing cells human promyelocyticleukemia cells packaging plasmids pcmvδr8 quantitate myeloid differentiation pathway analysis showed nuclear hormone 1alpha vdr transcriptional activity wnt/beta-catenin enhanced avian rt irreversible growth arrest circulating human aml rar-mediated differentiation enhance growth inhibition

Social Networks {👍}(6)

External Links {🔗}(79)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.26s.